Dr. Keren is a pediatric hospitalist and researcher who studies the effectiveness and cost-effectiveness of treatments for common diseases of childhood, such as neonatal jaundice, influenza, and urinary tract infections. His research has been funded by NIH, AHRQ, CDC, as well as other foundation grants. He is currently the principal investigator on three R01 grants including a multi-center randomized controlled trial of antibiotic prophylaxis for children with VUR (RIVUR study), a prospective cohort study of children with history of urinary tract infection but no VUR (CUTIE study), and a project to merge clinical and administrative data from six large children's hospitals for the performance of comparative effectiveness research (PROSPECT).
Infectious Diseases, Pediatrics, Newborn Screening
Dr. Keren studies the efficacy and cost-effectiveness of treatments for common problems in general pediatrics, i.e. prediction and prevention of newborn hyperbilirubinemia and kernicterus, the therapeutic and radiological management of children with urinary tract infections (UTIs) and the epidemiology and economics of influenza.
Clinical Trials, Diagnostic Testing, Health Services Research, Meta-analysis, Multivariate Analysis, Cost-Effective Analysis
- Associate Professor of Epidemiology in Biostatistics and Epidemiology at University of Pennsylvania School of Medicine (2008 – 2013)
- Associate Professor of Pediatrics at the Children's Hospital of Philadelphia (2008 – 2013)
- Assistant Professor of Pediatrics at the Children's Hospital of Philadelphia (2001 – 2008)
- Associate Professor of Surgery at University of Pennsylvania School of Medicine (2011– present)
- Professor of Pediatrics at the Children's Hospital of Philadelphia (2013– present)
- Professor of Epidemiology in Biostatistics and Epidemiology at University of Pennsylvania School of Medicine (2013– present)
- M.P.H., Clinical Effectiveness, Harvard School of Public Health (2001)
- M.D., New York University School of Medicine (1994)
- B.A., Philosophy, Princeton University (1989)
- Coffin SE, Leckerman K, Keren R, Hall M, Localio R, Zaoutis TE. Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study. Pediatr Infect Dis J. Vol 30(11) . 2011 Nov:962-6.
- Kim SS, Luan X, Canning DA, Landis JR, Keren R. Association between Bodym Mass Index and Urolithiasis in Children. J Urol. Vol 186(4 Suppl) . 2011 Oct:1734-9.
- McLeod L, French B, Dai D, Localio R, Keren R. Patient volume and quality of care for young children hospitalized with acute gastroenteritis. Arch Pediatr Adolesc Med. Vol 165(9) . 2011 Sep:857-63.
- Weiss PF, Klink AJ, Behrens EM, Sherry DD, Finkel TH, Feudtner C, Keren R. Enthesitis in an inception cohort of enthesitis-related arthritis. Arthritis Care Res. Vol 63(9) . 2011 Sep:1307-12.
- Narus SP, Srivastava R, Gouripeddi R, Livne OE, Mo P, Bickel JP, de Regt D, Hales JW, Kirkendall E, Stepanek RL, Toth J, Keren R. Federating Clinical Data from Six Pediatric Hospitals: Process and Initial Results from the PHIS+ Consortium. AMIA Annu Symp Proc. Vol 2011. 2011:994-1003.
- Weiss PF, Klink AJ, Localio R, Hall M, Hexem K, Burnham JM, Keren R, Feudtner C. Corticosteroids may improve clinical outcomes during hospitalization for Henoch Schönlein purpura. Pediatrics. Vol 126(4) . 2010 Oct:674-81.
- Paschke AA, Zaoutis T, Conway PH, Xie D, Keren R. Previous Antimicrobial Exposure Is Associated With Drug-Resistant Urinary Tract Infections in Children. Pediatrics. Vol 125(4) . 2010 Mar:664-72.
- Wood JN, Hall M, Keren R, Schilling S, Mitra N, Rubin DM. Disparities in the Evaluation and Diagnosis of Abuse Among Infants with Traumatic Brain Injury. Pediatrics. Vol 126(3) . 2010 Sep:408-14.
- Weiss PF, Klink AJ, Hexem K, Burnham JM, Leonard MB, Keren R, Localio R, Feudtner C. Variation in inpatient therapy and diagnostic evaluation of children with Henoch Schönlein purpura. J Pediatr. Vol 155(28) . 2009 Jul:812-818.e1..